Differential Expression of Protein Kinase C Subtypes during Ginsenoside Rh2-Induced Apoptosis in SK-N-BE(2) and C6Bu-1 Cells

Archives of Pharmacal Research

Volumn 23, Issue 5, 2000, Pages 518-524

  Kim, Young Sook ^a   Jin, Sung Ha ^a   Lee, You Hiu ^a   Park, Jong Dae ^a   Kim, Shin Il ^a  

^a Korea Ginseng Corporation   (South Korea)

Author keywords

Apoptosis; C6Bu 1 cells; Ginsenoside Rh2; Protein kinase C; Sk N BE(2) cells

Indexed keywords

GINSENOSIDE; GINSENOSIDE RH 2; HERBACEOUS AGENT; ISOENZYME; PROTEIN KINASE C; SAPONIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; DRUG EFFECT; HUMAN; PHYSIOLOGY; RAT;

ANIMALS; APOPTOSIS; DRUGS, CHINESE HERBAL; GINSENOSIDES; HUMANS; ISOENZYMES; PROTEIN KINASE C; RATS; SAPONINS; TUMOR CELLS, CULTURED;

EID: 0034304182     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976583     Document Type: Article

References (34)

1. Datta, R., Kojima, H., Yoshida, K. and Kufe, D., Caspase- 3-mediated cleavage of protein kinase C θ in induction of apoptosis. J. Biol. Chem., 272, 20317-20320 (1997).
2. Denning, M. F., Wang, Y., Nickoloff, B. J. and Wrone-Smith, T., Protein kinase C δ is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J. Biol. Chem., 273, 29995- 30002 (1998).
3. de Vente, J., Kiley, S., Garris, T., Bryant, W., Hooker, J., Posekany, K., Parker, P., Cook, P., Fletcher, D. and Ways, D. K., Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. Cell Growth & Differ., 6, 371-382 (1995).
4. Diaz-Meco, M. T., Municio, M. M., Frutos, S., Sanchez, P., Lozano, J., Sanz, L. and Moscat, J., The product of par4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinese C. Cell, 86, 777-786 (1996).
5. Emoto, Y., Kisaki, H., Manome, Y., Kharbanda, S. and Kufe, D., Activation of protein kinase C δ in human myeloid leukemia cells treated with 1-β-D-arabinofuranosylcytosine. Blood, 87, 1990-1996 (1996).
6. Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., Weichselbaum, R. and Kufe, D., Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J., 14, 6148-6156 (1995).
7. 2. Cancer J., 1, 349-352 (1987).
8. ∥ protein kinase C as a mitotic lamin kinase. J. Biol. Chem., 269, 19074-19080 (1994).
9. Hoffman, B. and Liebermann, D. A., Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive & negative modulators. Oncogene, 9, 1807- 1812 (1994).
10. Ito, T., Deng, X., Carr, B. and May, W.S., Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem., 272, 11671-11673 (1997).
11. L, or Bax in C6Bu-1 cells, Arch. Pharm. Res., 22, 448-453 (1999).
12. 2. Int. J. Biochem. Cell Biol., 30, 327-338 (1998).
13. Knox, K. A., Johnson, G. D. and Gordon, J., A study of protein kinase C isozyme distribution in relation to Bcl- 2 expression during apoptosis of epithelial cells in vivo. Exp. Cell. Res., 207, 68-73 (1993).
14. kip1. Cancer Lett., 110, 193-200 (1996).
15. Lee, Y. -N., Lee, H. -Y., Chang, H. Y., Kim, S. -I., Lee, S. -K., Park, B. -C. and Kim, K. -W., In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cells. Eur. J. Cancer, 32A, 1420-1428 (1996).
16. Macfarlane, D. E. and Manzel, L., Activation of β-isozyme of protein kinase C (PKCβ) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. J. Biol. Chem., 269, 4327-4331 (1994).
17. May, W. S., Tyler, P. G., Ito, T., Armstrong, D. K., Qatsha, K. A. and Davidson, N. E., Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2α in association with suppression of apoptosis. J. Biol. Chem., 269, 26865-26870 (1994).
18. Mayne, G. C. and Murray, A. W., Evidence that protein kinase C ε mediates phorbol ester inhibition of calphostin C- and tumor necrosis factor-α-induced apoptosis in U937 histiocytic lymphoma cells. J. Biol. Chem., 273, 24115-24121 (1998).
19. Murray, N. R. and Fields, A. P., Atypical protein kinase C protects human leukemia cells against drug-induced apoptosis. J. Biol. Chem., 272, 27521-27524 (1997).
20. Nishizuka, Y., Studies and perspectives of protein kinase C. Science, 233, 305-312 (1986).
21. Nishizuka, Y., Intracelluar signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258, 607-614 (1992).
22. Odashima, S., Ohta, T., Kohno, H., Matsuda, T., Kitakawa, I., Abe, H. and Arichi, S., Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res., 45, 2781-2784 (1985).
23. Ota, T., Fujikawa-Yamamoto, K., Zong, Z. -P., Yamazaki, M., Odashima, S., Kitakawa, I., Abe, H. and Arichi, S., Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res., 47, 3863-3867 (1987).
24. Park, J. A., Lee, K. Y., Oh, Y. J., Kim, K. W. and Lee, S. K., Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2- induced apoptosis. Cancer Lett., 121, 73-81 (1997).
25. Pongracz, J., Deacon, E. M., Johnson, G. D., Burnett, D. and Lord, J. M., Doppa induces cell death but not differentiation of U937 cells: evidence for involvement of PKC-β1 in the regulation of apoptosis. Leukemia Res., 20, 319-326 (1996).
26. Pongracz, J., Tuffley, W., Johnson, G. D., Deacon, E. M., Burnett, D., Stockley, R. A. and Lord, J. M., Changes in protein kinase C isoenzyme expression associated with apoptosis in U937 myelomonocytic cells. Exp. Cell. Res., 218, 430-438 (1995).
27. Sawai, H., Okazaki, T., Takeda, Y., Tashima, M., Sawada, H., Okuma, M., Kishi, S., Umehara, H. and Domae, N., Ceramide induced translocation of protein kinase C-δ and -ε to the cytosol. J. Biol. Chem., 272, 2452-2458 (1997).
28. Shimizu, T., Cao, C. -X., Shao, R. -G. and Pommier, Y., Lamin B phosphorylation by protein kinase C α and proteolysis during apoptosis in human leukemia HL60 cells. J. Biol. Chem., 273, 8669-8674 (1998).
29. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst., 82, 1107-1112 (1990).
30. Steller, H., Mechanisms and genes of cellular suicide. Science, 267, 1445-1449 (1995).
31. Takenaka, I., Morin, F., Seizinger, B. R. and Kley, N., Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem., 270, 5405-5411 (1995).
32. Thompson, C. B., Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462 (1995).
33. Vaux, D. L., Haecker, G. and Strasser, A., An evolutionary perspective on apoptosis. Cell, 76, 777-779 (1994).
34. Zeidman, R., Pettersson, L., Sailaja, P. R., Truedsson, E., Fagerström, S., Pahlman, S. and Larsson, C., Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells. Int. J. Cancer, 81, 494-501 (1999).